ES2525718T3 - Reparación y regeneración de tejido renal mediante células derivadas de tejido de cordón umbilical humano - Google Patents

Reparación y regeneración de tejido renal mediante células derivadas de tejido de cordón umbilical humano Download PDF

Info

Publication number
ES2525718T3
ES2525718T3 ES08835175.4T ES08835175T ES2525718T3 ES 2525718 T3 ES2525718 T3 ES 2525718T3 ES 08835175 T ES08835175 T ES 08835175T ES 2525718 T3 ES2525718 T3 ES 2525718T3
Authority
ES
Spain
Prior art keywords
umbilical cord
protein
tissue
cord tissue
human umbilical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08835175.4T
Other languages
English (en)
Inventor
David Colter
Anna Gosiewska
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DePuy Synthes Products Inc
Original Assignee
DePuy Synthes Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DePuy Synthes Products Inc filed Critical DePuy Synthes Products Inc
Application granted granted Critical
Publication of ES2525718T3 publication Critical patent/ES2525718T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Células obtenidas de tejido de cordón umbilical humano para su uso en el tratamiento de un paciente con lesión o insuficiencia renal aguda o enfermedad renal crónica, en el que el tejido de cordón umbilical está sustancialmente libre de sangre, y en el que las células son capaces de autorrenovarse y desarrollarse en cultivo y tienen el potencial de diferenciarse; necesitan L-valina para crecer; son capaces de crecer en atmósferas que contienen oxígeno del 5% al 20%; no producen CD117 ni HLA-DR; expresan alfa-actina de músculo liso; y expresan, en comparación con una célula madre mesenquimal, célula de médula ósea de cresta ilíaca o fibroblasto humano, mayores niveles de receptor 1 de lipoproteínas de baja densidad oxidadas, interleucina 8 o reticulón 1.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
E08835175
10-12-2014
Tabla 4
5
15
25
35
45
55
Los genes demostraron tener una expresión disminuida en las células derivadas de tejido de cordón umbilical en comparación con otras líneas celulares ensayadas
Genes disminuidos en las células derivadas de placenta y derivadas de tejido de cordón umbilical
ID del conjunto de sondas
Nombre el gen Número de registro del NCBI
210135_ s_at
caja homeótica de la baja estatura 2 AF022654.1
205824_at
proteína 2 de choque térmico de 27 kDa NM_001541.1
209687_at
ligando 12 de quimiocina (motivo C-X-C ) (factor 1 derivado de células del estroma) U19495.1
203666_at
ligando 12 de quimiocina (motivo C-X-C ) (factor 1 derivado de células del estroma) NM_000609.1
212670_at
elastina (estenosis aórtica supravalvular, síndrome de Williams-Beuren) AA479278
213381_at
ARNm de Homo sapiens; ADNc DKFZp586M2022 (del clon DKFZp586M2022) N91149
206201_s_at
caja homeótica de mesénquima 2 (caja homeótica específica de la detención del crecimiento) NM_005924.1
205817_at
homólogo 1 de caja homeótica de “sine oculis” (Drosophila) NM_005982.1
209283_at
cristalino, alfa B AF007162.1
212793_at
activador 2 de la morfogénesis asociado a “disheveled” BF513244
213488_at
proteína DKFZP586B2420 AL050143.1
209763_at
similar a neuralina 1 AL049176
205200_at
tetranectina (proteína de unión a plasminógeno) NM_003278.1
205743_at
de homología con src tres (SH3) y dominio rico en cisteína NM_003149.1
200921_s_at
gen 1 de translocación de linfocitos B, anti-proliferativa NM_001731.1
206932_at
colesterol 25-hidroxilasa NM_003956.1
204198_s_at
factor de transcripción 3 relacionado con enanismo AA541630
219747_at
proteína hipotética FLJ23191 NM_024574.1
204773_at
receptor de interleucina 11, alfa NM_004512.1
202465_at
potenciador de procolágeno C-endopeptidasa NM_002593.2
203706_s_at
homólogo 7 de “frizzled“ (Drosophila) NM_003507.1
212736_at
gen hipotético BC008967 BE299456
214587_at
colágeno, tipo VIII, alfa 1 BE877796
201645_at
tenascina C (hexabraquion) NM_002160.1
210239_at
proteína 5 de la caja homeótica de “iroquois“ U90304.1
203903_s_at
hepaestina NM_014799.1
205816_at
integrina, beta 8 NM_002214.1
203069_at
glicoproteína 2 de las vesículas sinápticas NM_014849.1
213909_at
ADNc FLJ12280 fis de Homo sapiens, clon MAMMA1001744 AU147799
206315_at
factor 1 similar a receptor de citocinas NM_004750.1
204401_at
canal de potasio activado por calcio de conductancia intermedia/baja, subfamilia N, miembro 4 NM_002250.1
216331_at
integrina, alfa 7 AK022548.1
209663_s_at
integrina, alfa 7 AF072132.1
213125_at
proteína DKFZP586L151 AW007573
202133_at
coactivador de la transcripción con motivo de unión a PDZ (TAZ) AA081084
206511_s_at
homólogo 2 de la caja homeótica de “sine oculis” (Drosophila) NM_016932.1
213435_at
proteína KIAA1034 AB028957.1
206115_at
de respuesta de crecimiento precoz 3 NM_004430.1
213707_s_at
caja homeótica 5 de “distal-less” NM_005221.3
19
E08835175
10-12-2014
5
15
25
218181_s_at
proteína hipotética FLJ20373 NM_017792.1
209160_ at
familia 1 de aldo-ceto reductasa, miembro C3 (3-alfa hidroxiesteroide deshidrogenasa, tipo II) AB018580.1
213905_x_at
biglicano AA845258
201261_x_at
biglicano BC002416.1
202132_at
coactivador de la transcripción con motivo de unión a PDZ (TAZ) AA081084
214701_s_at
fibronectina 1 AJ276395.1
213791_at
proencefalina NM_006211.1
205422_s_at
integrina, similar a beta 1 (con dominios de repetición de tipo EGF) NM_004791.1
214927_at
clon EUROIMAGE 1968422 de ADNc de inserto de longitud completa de ARNm de Homo sapiens AL359052.1
206070_s_at
EphA3 AF213459.1
212805_at
proteína KIAA0367 AB002365.1
219789_at
receptor C del péptido natriurético/guanilato ciclasa C (receptor C del péptido atrial natriurético) AI628360
219054_at
proteína hipotética FLJ14054 NM_024563.1
213429_at
ARNm de Homo sapiens; ADNc DKFZp564B222 (del clon DKFZp564B222) AW025579
204929_s_at
proteína 5 de membrana asociada a vesículas (miobrevina) NM_006634.1
201843_s_at
proteína 1 de la matriz extracelular de tipo fibulina que contienen EGF NM_004105.2
221478_at
similar a proteína 3 de interacción con BCL2/adenovirus E1B 19kDa AL132665.1
201792_at
proteína 1 de unión a AE NM_001129.2
204570_at
polipéptido 1 de la subunidad VIIa de la citocromo c oxidasa (músculo) NM_001864.1
201621_at
neuroblastoma, supresión de tumorigenicidad 1 NM_005380.1
202718_at
proteína 2 de unión al factor de crecimiento insulinoide, de 36kDa NM_000597.1
Las tablas 5, 6 y 7 muestran la expresión de genes aumentada en fibroblastos humanos (Tabla 5), células ICBM (Tabla 6) y MSC (Tabla 7).
Tabla 5
45
55
Genes que demostraron tener una expresión aumentada en los fibroblastos en comparación con las demás líneas celulares ensayadas
Genes aumentados en fibroblastos
fosfatasa de doble especificidad 2
proteína KIAA0527
ADNc de Homo sapiens: FLJ23224 fis, clon ADSU02206
dineína, citoplasmática, polipéptido intermedio 1
anquirina 3, nódulo de Ranvier (anquirina G)
inhibina, beta A (activina A, activina AB, polipéptido alfa)
ectonucleótido pirofosfatasa/fosfodiesterasa 4 (función supuesta)
proteína KIAA1053
proteína asociada a microtúbulos 1A
proteína con dedos de zinc 41
proteína HSPC019
ADNc de Homo sapiens: FLJ23564 fis, clon LNG10773
ARNm de Homo sapiens; ADNc DKFZp564A072 (del clon DKFZp564A072)
Proteína LIM (similar a enigma de unión a proteína quinasa C de rata)
inhibidor del potenciador del gen del polipéptido de cadena ligera kappa en los linfocitos B, proteína asociada a complejo quinasa
proteína hipotética FLJ22004
Secuencia de ARNm humano (clon CTG-A4)
EST, Moderadamente similares al factor 2 de tipo receptor de citocinas; precursor del receptor de citocinas CRL2 [Homo sapiens]
20
imagen18
imagen19
imagen20
imagen21
imagen22
imagen23
E08835175
10-12-2014
5
15
25
35
45
55
IM042479 Medida inicial de la proliferación del receptor Control de autoestimulación (células autólogas tratadas con mitomicina C) Donante alogénico MLR IM04-2477 (tratado con mitomicina C) MLR con línea celular (célula tratada con mitomicina C, tipo A) SI (donante) SI (línea celular) IM042480 Medida inicial de la proliferación del receptor Control de autoestimulación (células autólogas tratadas con mitomicina C) Donante alogénico MLR IM04-2477 (tratado con mitomicina C) MLR con línea celular (célula tratada con mitomicina C, tipo A) SI (donante) SI (línea celular) IM042481 Medida inicial de la proliferación del receptor Control de autoestimulación (células autólogas tratadas con mitomicina C) Donante alogénico MLR IM04-2477 (tratado con mitomicina C) MLR con línea celular (célula tratada con mitomicina C, tipo A) SI (donante) SI (línea celular) Número de análisis Sistema de cultivo IM042482 Medida inicial de la proliferación del receptor Control de autoestimulación (células autólogas tratadas con mitomicina C) Donante alogénico MLR IM04-2477 (tratado con mitomicina C) MLR con línea celular (célula tratada con mitomicina C, tipo A) SI (donante) SI (línea celular)
530 508 701 567 25593 24732 5086 3932 1192 854 2963 993 25416 29721 2596 5076 695 451 738 1252 13177 24885 4495 3671 ID de placa: Placa 2 Repetic iones 1 2 432 533 1459 633 24286 30823 2762 1502 527 1111 22707 1497 1330 2197 23757 3426 555 464 15444 4674 3 274 598 31346 6723 521,7 793,0 24344,0 3505,0 47 7 1125,3 2051,0 26298,0 3699,3 23 3 567,0 818,0 17835,3 4280,0 31 8 Media 413.0 896.7 28818.3 3662.3 70 9 11,93 283,43 1481,61 1832,21 244,90 993,08 3078,27 1262,39 122,44 400,04 6209,52 534,95 DE 130.54 487.31 3933.82 2724.46 2,3 35,7 6,1 52,3 21,8 48,4 11,7 34,1 21,6 48,9 34,8 12,5 CV 31.6 54.3 13.7 74.4
27
imagen24
imagen25
imagen26
imagen27
imagen28
E08835175
10-12-2014
17,45
25,46 269,38
18,56
78,26
18,41
17,30
Promedio
17,33 54,25 97,28 114,4 3
Est:
3,04 36,41 64,75 94,15
EEM
0,81 10,51 19,52 54,36
La Tabla 20 y la Figura 4 muestran las mediciones de SCr de las muestras de suero del día 5. El tratamiento con HBSS y mMSC dio como resultado valores medios de creatinina de 0,74 mg/dl y 0,66 mg/dl, respectivamente. Se observó una reducción estadísticamente significativa en la SCr después del tratamiento con hMSC o hUTC a menor dosis (P < 0,03). El tratamiento con hMSC dio como resultado un valor medio de SCr de 0,47 mg/dl y el tratamiento con hUTC a menor dosis dio como resultado un valor medio de SCr de 0,57 mg/dl.
Tabla 20
25
35
45
Creatinina sérica. La Crs se midió el día 5 después del trasplante de las células. Desviación estándar (est.). Error estándar de la media (EEM)
Grupo de tratamiento
Material de ensayo Creatinina mg/dl Media Est. EEM Valor de p
1
HBSS HBSS HBSS HBSS HBSS 0,64 0,72 0,72 0,89 0,73 0,74 0,09 0,04 na
2
mMSC mMSC mMSC mMSC mMSC 0,64 0,72 0,72 0,48 0,72 0,66 0,10 0,05 0,213
3
hMSC hMSC hMSC hMSC 0,24 0,27 0,56 0,56 0,47 0,21 0,09 0,008
4
hUTC hUTC hUTC hUTC 0,64 0,45 0,56 0,64 0,57 0,08 0,03 0,028
5
hUTC hUTC hUTC hUTC 1,28 0,26 0,48 0,72 0,68 0,38 0,17 0,789
El día 7 después del trasplante de las células, se sacrificaron dos ratones por grupo de tratamiento y se fijaron los tejidos mediante perfusión transcardíaca con solución salina, seguido de perfusión e inmersión en paraformaldehído al 4%. Se extirparon los riñones de los ratones y se procesaron para la histología. A continuación se evaluaron los cortes teñidos con H&E para la lesión histológica. Dos patólogos entrenados realizaron
55 evaluaciones con enmascaramiento y puntuaron el grado de degeneración tubular renal.
Se midió cualitativamente la necrosis tubular en los cortes histológicos de animales tratados con HBSS, hMSC y hUTC a menor dosis. Se puntuó la degeneración tubular en una escala que iba de 1 a 4 (1 = daño mínimo, 2 = daño leve, 3 = daño moderado, 4 = daño grave). Como se muestra en la Tabla 21 y en la Figura 5, el tratamiento con vehículo y con hMSC dio como resultado una degeneración tubular leve, con una puntuación media de lesión de 2,5. Sin embargo, un tratamiento con hUTC a menor dosis dio como resultado daño tubular mínimo con una puntuación media de lesión de 1,9, que indicaba el potencial renoprotector de las hUTC.
65
33
imagen29
imagen30
imagen31
imagen32

Claims (1)

  1. imagen1
    imagen2
ES08835175.4T 2007-10-05 2008-10-03 Reparación y regeneración de tejido renal mediante células derivadas de tejido de cordón umbilical humano Active ES2525718T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97777507P 2007-10-05 2007-10-05
US977775P 2007-10-05
PCT/US2008/078800 WO2009046335A1 (en) 2007-10-05 2008-10-03 Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells

Publications (1)

Publication Number Publication Date
ES2525718T3 true ES2525718T3 (es) 2014-12-29

Family

ID=40523441

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08835175.4T Active ES2525718T3 (es) 2007-10-05 2008-10-03 Reparación y regeneración de tejido renal mediante células derivadas de tejido de cordón umbilical humano

Country Status (10)

Country Link
US (1) US8034329B2 (es)
EP (1) EP2203186B1 (es)
JP (1) JP5323845B2 (es)
CN (1) CN102036688B (es)
AU (1) AU2008308531B2 (es)
BR (1) BRPI0818183A2 (es)
CA (1) CA2701435C (es)
ES (1) ES2525718T3 (es)
UA (1) UA99152C2 (es)
WO (1) WO2009046335A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
ES2564044T3 (es) 2003-06-27 2016-03-17 DePuy Synthes Products, Inc. Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas
US8491883B2 (en) * 2003-06-27 2013-07-23 Advanced Technologies And Regenerative Medicine, Llc Treatment of amyotrophic lateral sclerosis using umbilical derived cells
US7875272B2 (en) * 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US8790637B2 (en) * 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US8518390B2 (en) 2003-06-27 2013-08-27 Advanced Technologies And Regenerative Medicine, Llc Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US8236538B2 (en) 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
AU2008343203B2 (en) * 2007-12-27 2014-07-10 DePuy Synthes Products, LLC Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
DK2330889T3 (en) 2008-08-20 2017-01-30 Anthrogenesis Corp Improved cell composition and process for making the same
HRP20130812T1 (en) 2008-08-22 2013-09-30 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
CN102282252B (zh) 2008-11-19 2017-07-04 人类起源公司 羊膜来源的贴壁细胞
BRPI0923068B1 (pt) 2008-12-19 2021-05-25 Advanced Technologies And Regenerative Medicine, Llc Uso de células derivadas de tecido de cordão umbilical para tratar um paciente tendo uma doença, distúrbio ou injúria pulmonar
WO2010071863A1 (en) * 2008-12-19 2010-06-24 Ethicon, Incorporated Regeneration and repair of neural tissue following injury
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
CN102498204B (zh) * 2009-03-26 2015-02-04 德普伊新特斯产品有限责任公司 人脐带组织细胞作为用于阿尔茨海默病的疗法
US8796315B2 (en) 2009-06-25 2014-08-05 Darlene E. McCord Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
WO2011126833A2 (en) * 2010-03-29 2011-10-13 Massachusetts Institute Of Technology Anti-inflammatory factors
MX2012011543A (es) 2010-04-08 2013-05-06 Anthrogenesis Corp Tratamiento de sarcoidosis empleando celulas madre placentarias.
WO2011153205A1 (en) 2010-06-01 2011-12-08 Auxocell Laboratories, Inc. Native wharton's jelly stem cells and their purification
AU2011352036A1 (en) 2010-12-31 2013-07-18 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
CN104220081A (zh) 2011-06-01 2014-12-17 人类起源公司 利用胎盘干细胞治疗疼痛
JP6301263B2 (ja) * 2011-12-23 2018-03-28 デピュイ・シンセス・プロダクツ・インコーポレイテッド ヒト臍帯組織由来細胞の検出
US20150284689A1 (en) * 2012-10-26 2015-10-08 The Regents Of The University Of California Strategy for engineering various 3d tissues, organoids and vasculature
US9144555B2 (en) 2012-11-30 2015-09-29 Darlene E. McCord Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
JP2016512555A (ja) * 2013-03-14 2016-04-28 アントフロゲネシス コーポレーション 急性腎損傷の治療における胎盤幹細胞の使用
CN107076638B (zh) 2014-10-28 2019-10-25 康明斯排放处理公司 Scr转化效率诊断
JP2019535323A (ja) * 2016-11-15 2019-12-12 レグロー バイオサイエンシズ プライベート リミティッド 頬上皮細胞懸濁液の調製方法及びその使用
JP7391327B2 (ja) 2018-01-12 2023-12-05 国立大学法人大阪大学 重層扁平上皮細胞の正常分化・成熟促進剤、上皮疾患治療剤及び重層扁平上皮細胞の正常分化・成熟促進方法
CN112569408B (zh) * 2020-12-01 2021-12-07 暨南大学 组织工程补片及其制备方法

Family Cites Families (156)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US4963489A (en) 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5902741A (en) 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
JPS642643A (en) 1987-06-26 1989-01-06 Bio Material Yunibaasu:Kk Artificial skin
NZ226750A (en) 1987-10-29 1990-09-26 Amrad Corp Ltd Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene
US5004681B1 (en) 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5192553A (en) 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US20030032178A1 (en) 1988-08-04 2003-02-13 Williams Robert Lindsay In vitro propagation of embryonic stem cells
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5840580A (en) 1990-05-01 1998-11-24 Becton Dickinson And Company Phenotypic characterization of the hematopoietic stem cell
US5342761A (en) 1990-10-01 1994-08-30 Research Development Foundation Oncofetal gene, gene product and uses therefor
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5286632A (en) 1991-01-09 1994-02-15 Jones Douglas H Method for in vivo recombination and mutagenesis
US6399369B1 (en) 1991-07-08 2002-06-04 Neurospheres Holdings Ltd. Multipotent neural stem cell cDNA libraries
AU4543193A (en) 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
US5320962A (en) 1992-07-22 1994-06-14 Duke University DNA encoding the human A1 adenosine receptor
US5589376A (en) 1992-07-27 1996-12-31 California Institute Of Technology Mammalian neural crest stem cells
ATE250138T1 (de) 1992-10-29 2003-10-15 Univ Australian Angiogenese-inhibierende antikörper
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5955343A (en) 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5707643A (en) 1993-02-26 1998-01-13 Santen Pharmaceutical Co., Ltd. Biodegradable scleral plug
IL110589A0 (en) 1993-08-10 1994-11-11 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF- beta family
US6686198B1 (en) 1993-10-14 2004-02-03 President And Fellows Of Harvard College Method of inducing and maintaining neuronal cells
US6432711B1 (en) 1993-11-03 2002-08-13 Diacrin, Inc. Embryonic stem cells capable of differentiating into desired cell lines
US5698518A (en) 1994-03-30 1997-12-16 Oklahoma Medical Research Foundation Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists
US5834308A (en) 1994-04-28 1998-11-10 University Of Florida Research Foundation, Inc. In vitro growth of functional islets of Langerhans
US6703017B1 (en) 1994-04-28 2004-03-09 Ixion Biotechnology, Inc. Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
US6001647A (en) 1994-04-28 1999-12-14 Ixion Biotechnology, Inc. In vitro growth of functional islets of Langerhans and in vivo uses thereof
US5725493A (en) 1994-12-12 1998-03-10 Avery; Robert Logan Intravitreal medicine delivery
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US5641750A (en) 1995-11-29 1997-06-24 Amgen Inc. Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
US6200606B1 (en) 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US5842477A (en) 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
CN1263852C (zh) 1996-03-15 2006-07-12 穆尼恩公司 胞外基质信号分子
CA2253724A1 (en) 1996-04-26 1997-11-06 Case Western Reserve University Skin regeneration using mesenchymal stem cells
US6787355B1 (en) 1996-08-26 2004-09-07 Mcgill University Multipotent neural stem cells from peripheral tissues and uses thereof
US5919702A (en) 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
CA2291718A1 (en) 1997-05-30 1998-12-03 Osteobiologics, Inc. Fiber-reinforced, porous, biodegradable implant device
US5902598A (en) 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6391297B1 (en) 1997-12-02 2002-05-21 Artecel Sciences, Inc. Differentiation of adipose stromal cells into osteoblasts and uses thereof
US6291240B1 (en) 1998-01-29 2001-09-18 Advanced Tissue Sciences, Inc. Cells or tissues with increased protein factors and methods of making and using same
ES2237089T3 (es) 1998-03-13 2005-07-16 Osiris Therapeutics, Inc. Usos para celulas madre mesenquimatosas humanas no autologas.
US6171610B1 (en) 1998-04-24 2001-01-09 University Of Massachusetts Guided development and support of hydrogel-cell compositions
ES2246085T3 (es) 1998-05-07 2006-02-01 University Of South Florida Celulas de medula osea como fuente de neuronas util para reparar la medula espinal y el cerebro.
CA2328524A1 (en) 1998-05-29 1999-12-02 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
US6323188B1 (en) 1998-07-01 2001-11-27 Donald L. Weissman Treatment and prevention of cardiovascular diseases, heart attack, and stroke, primary and subsequent, with help of aspirin and certain vitamins
US20040037818A1 (en) 1998-07-30 2004-02-26 Brand Stephen J. Treatment for diabetes
US5958767A (en) 1998-08-14 1999-09-28 The Children's Medical Center Corp. Engraftable human neural stem cells
US6284245B1 (en) 1998-08-25 2001-09-04 Diacrin, Inc. Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders
US6444205B2 (en) 1998-09-30 2002-09-03 Diacrin, Inc. Transplantation of neural cells for the treatment of chronic pain or spasticity
US6610540B1 (en) 1998-11-18 2003-08-26 California Institute Of Technology Low oxygen culturing of central nervous system progenitor cells
AU781750B2 (en) 1999-02-04 2005-06-09 Mcgill University Platform for the differentiation of cells
CA2362593A1 (en) 1999-02-10 2000-08-17 Curis, Inc. Pancreatic progenitor cells, methods and uses related thereto
US20030007954A1 (en) 1999-04-12 2003-01-09 Gail K. Naughton Methods for using a three-dimensional stromal tissue to promote angiogenesis
JP2002542349A (ja) 1999-04-16 2002-12-10 ダブリューエム・マーシュ・ライス・ユニバーシティー ポリ（プロピレンフマラート）−ジアクリレートマクロマーで交差結合された生体分解性のポリ（プロピレンフマラート）ネットワーク
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6287340B1 (en) 1999-05-14 2001-09-11 Trustees Of Tufts College Bioengineered anterior cruciate ligament
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
US6333029B1 (en) 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US6429013B1 (en) 1999-08-19 2002-08-06 Artecel Science, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US20030129745A1 (en) 1999-10-28 2003-07-10 Robl James M. Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
US20030082155A1 (en) 1999-12-06 2003-05-01 Habener Joel F. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US20020164307A1 (en) 1999-12-06 2002-11-07 Habener Joel F. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
JP2003523323A (ja) 1999-12-06 2003-08-05 ザ ジェネラル ホスピタル コーポレーション 膵臓幹細胞および移植におけるその使用
WO2001053503A1 (en) 2000-01-18 2001-07-26 Cornell Research Foundation, Inc. Neural progenitor cells from hippocampal tissue and a method for isolating and purifying them
US7544509B2 (en) 2000-01-24 2009-06-09 Mcgill University Method for preparing stem cell preparations
US6610535B1 (en) 2000-02-10 2003-08-26 Es Cell International Pte Ltd. Progenitor cells and methods and uses related thereto
WO2001059072A1 (en) 2000-02-11 2001-08-16 Philadelphia Health And Education Corporation Differentiation of bone marrow cells into neuronal cells and uses therefor
ATE473751T1 (de) 2000-02-11 2010-07-15 Schepens Eye Res Inst Isolierung und transplantation von retinalen stammzellen
EP1263930A4 (en) 2000-03-09 2004-07-21 Saneron Ccel Therapeutics Inc HUMAN CORD BLOOD BLOOD AS A SOURCE FOR NEURAL TISSUE FOR HEALING THE BRAIN AND BACK MARK
US6436704B1 (en) 2000-04-10 2002-08-20 Raven Biotechnologies, Inc. Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
US6673606B1 (en) 2000-04-12 2004-01-06 The Children's Hospital Of Philadelphia Therapeutic uses for mesenchymal stromal cells
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
AU6459801A (en) 2000-05-12 2001-11-26 Mark T Keating Compositions and methods for cell dedifferentiation and tissue regeneration
US8273570B2 (en) 2000-05-16 2012-09-25 Riken Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells
US6759039B2 (en) 2000-06-30 2004-07-06 Amcyte, Inc. Culturing pancreatic stem cells having a specified, intermediate stage of development
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
AU2001293586A1 (en) 2000-09-29 2002-04-08 Vincent Tropepe Primitive neural stem cells and method for differentiation of stem cells to neural cells
US20020098584A1 (en) 2000-11-06 2002-07-25 Palmer Theo D. Postmortem stem cells
WO2002102997A2 (en) 2000-11-30 2002-12-27 Stemron Inc. Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
EP2206772A3 (en) 2000-12-06 2010-08-04 Robert J. Hariri Method of collecting placental stem cells
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US6599323B2 (en) 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
US7449180B2 (en) 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
CA2437957C (en) 2001-02-14 2014-04-22 Robert J. Hariri Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
EP2336299A1 (en) 2001-02-14 2011-06-22 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
JP2004526449A (ja) 2001-03-29 2004-09-02 イクシオン・バイオテクノロジー・インコーポレーテッド 非膵性幹細胞の膵分化経路への分化転換法
US20030211605A1 (en) 2001-05-01 2003-11-13 Lee Sang-Hun Derivation of midbrain dopaminergic neurons from embryonic stem cells
US20030022369A1 (en) 2001-05-18 2003-01-30 Helen Fillmore Differentiation of specialized dermal and epidermal cells into neuronal cells
WO2002096203A1 (en) 2001-05-25 2002-12-05 Cythera, Inc. Stem cell differentiation
CN1349845A (zh) * 2001-06-22 2002-05-22 高大勇 分离脐血干细胞防冻剂的透析方法及透析装置
ATE443758T1 (de) 2001-08-08 2009-10-15 Levesque Biosciences Inc Zusammensetzungen und verfahren zur isolierung, vermehrung und differenzierung nicht-embryonale menschlicher stammzellen und deren verwendungen
US20030211603A1 (en) 2001-08-14 2003-11-13 Earp David J. Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
WO2003018767A2 (en) 2001-08-27 2003-03-06 Advanced Cell Technology, Inc. Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
US20030104997A1 (en) 2001-09-05 2003-06-05 Black Ira B. Multi-lineage directed induction of bone marrow stromal cell differentiation
CN1195055C (zh) 2001-09-06 2005-03-30 周胜利 从胎盘组织中提取造血干细胞用于建立造血干细胞库的新方法
WO2003033697A1 (en) 2001-10-18 2003-04-24 Ixion Biotechnology, Inc. Conversion of liver stem and progenitor cells to pancreatic functional cells
US7129034B2 (en) 2001-10-25 2006-10-31 Cedars-Sinai Medical Center Differentiation of whole bone marrow
EP1453954A4 (en) 2001-11-09 2004-12-15 Artecel Sciences Inc Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
JP3728750B2 (ja) 2001-11-22 2005-12-21 ニプロ株式会社 培養皮膚及びその製造方法
WO2003054171A1 (en) 2001-12-06 2003-07-03 The Regents Of The University Of California Method for differentiating islet precursor cells into beta cells
CN101240262A (zh) 2001-12-07 2008-08-13 杰龙公司 源自人胚胎干细胞的胰岛细胞
JP3934539B2 (ja) 2001-12-12 2007-06-20 独立行政法人科学技術振興機構 胎盤等由来の成体又は生後組織の前駆細胞
US20030113910A1 (en) 2001-12-18 2003-06-19 Mike Levanduski Pluripotent stem cells derived without the use of embryos or fetal tissue
IL162648A0 (en) 2001-12-21 2005-11-20 Mount Sinai Hospital Corp Cellular compositions and methods of making and using them
US7101546B2 (en) 2001-12-21 2006-09-05 Amcyte, Inc. In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development
AU2003202988A1 (en) 2002-01-14 2003-07-30 The Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
US20030162290A1 (en) 2002-01-25 2003-08-28 Kazutomo Inoue Method for inducing differentiation of embryonic stem cells into functioning cells
WO2003070189A2 (en) 2002-02-15 2003-08-28 Cornell Research Foundation, Inc. Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
US20030161818A1 (en) * 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
US7150990B2 (en) 2002-03-06 2006-12-19 Reprocell, Inc. Self-renewing pluripotent hepatic stem cells
US7498171B2 (en) 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
JP4136434B2 (ja) 2002-04-17 2008-08-20 進 清野 インスリン産生細胞の誘導
AU2003239159A1 (en) 2002-04-19 2003-11-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Placental derived stem cells and uses thereof
US20030228295A1 (en) 2002-04-25 2003-12-11 Svendsen Clive N. Use of human neural stem cells secreting GDNF for treatment of parkinson's and other neurodegenerative diseases
US20040029269A1 (en) 2002-05-07 2004-02-12 Goldman Steven A Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells
WO2003094965A2 (en) 2002-05-08 2003-11-20 Neuronova Ab Modulation of neural stem cells with s1p or lpa receptor agonists
AU2003247514A1 (en) 2002-06-11 2003-12-22 Roy Ogle Meningeal-derived stem cells
US7285415B2 (en) 2002-07-11 2007-10-23 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US7390659B2 (en) 2002-07-16 2008-06-24 The Trustees Of Columbia University In The City Of New York Methods for inducing differentiation of embryonic stem cells and uses thereof
JP2005532810A (ja) 2002-07-16 2005-11-04 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム 組織修復および組織形成のために間葉性幹細胞を移植する方法
US20040063202A1 (en) 2002-08-28 2004-04-01 Petersen Bryon E. Neurogenesis from hepatic stem cells
US9969977B2 (en) 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
JP4571387B2 (ja) 2003-02-07 2010-10-27 宣男 櫻川 ヒト羊膜由来サイドポピュレーション細胞及びその用途
WO2004072273A1 (en) 2003-02-11 2004-08-26 Davies John E Progenitor cells from wharton's jelly of human umbilical cord
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
ES2564044T3 (es) * 2003-06-27 2016-03-17 DePuy Synthes Products, Inc. Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas
AU2005322060B2 (en) * 2003-06-27 2011-11-17 Ethicon Incorporated Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US8039258B2 (en) 2004-09-28 2011-10-18 Ethicon, Inc. Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
US20060153815A1 (en) 2004-12-21 2006-07-13 Agnieszka Seyda Tissue engineering devices for the repair and regeneration of tissue
WO2006083394A2 (en) 2004-12-21 2006-08-10 Ethicon, Inc. Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
US20060171930A1 (en) 2004-12-21 2006-08-03 Agnieszka Seyda Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
WO2006071802A2 (en) 2004-12-23 2006-07-06 Ethicon Incorporated Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
CN101374946B (zh) 2005-12-16 2017-07-18 伊西康公司 用于在组织相容性不匹配的移植中抑制有害的免疫反应的组合物和方法
AU2006327073B2 (en) 2005-12-19 2012-08-30 Ethicon, Inc. In vitro expansion of postpartum derived cells in roller bottles
SG170789A1 (en) 2005-12-28 2011-05-30 Ethicon Inc Treatment of peripheral vascular disease using postpartum-derived cells
ES2708933T3 (es) 2005-12-29 2019-04-12 Celularity Inc Poblaciones de células madre placentarias
ES2432395T3 (es) 2006-10-12 2013-12-03 Ethicon, Inc. Células derivadas de riñon y metodo de uso en la reparación y regeneración tisular
ES2524443T3 (es) 2006-11-13 2014-12-09 DePuy Synthes Products, LLC Expansión in vitro de células postparto usando microportadores
US20080305148A1 (en) 2007-03-19 2008-12-11 National Yang Ming University Treatment of spinal injuries using human umbilical mesenchymal stem cells
US8236538B2 (en) 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
AU2008343203B2 (en) 2007-12-27 2014-07-10 DePuy Synthes Products, LLC Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
WO2010071863A1 (en) 2008-12-19 2010-06-24 Ethicon, Incorporated Regeneration and repair of neural tissue following injury
BRPI0923068B1 (pt) 2008-12-19 2021-05-25 Advanced Technologies And Regenerative Medicine, Llc Uso de células derivadas de tecido de cordão umbilical para tratar um paciente tendo uma doença, distúrbio ou injúria pulmonar
PT2379087E (pt) 2008-12-19 2014-12-02 Depuy Synthes Products Llc Células derivadas do tecido do cordão umbilical para o tratamento da dor neuropática e espasticidade
CN102498204B (zh) 2009-03-26 2015-02-04 德普伊新特斯产品有限责任公司 人脐带组织细胞作为用于阿尔茨海默病的疗法

Also Published As

Publication number Publication date
JP2010540662A (ja) 2010-12-24
CN102036688A (zh) 2011-04-27
US20090092653A1 (en) 2009-04-09
BRPI0818183A2 (pt) 2019-07-16
EP2203186A1 (en) 2010-07-07
AU2008308531A1 (en) 2009-04-09
UA99152C2 (ru) 2012-07-25
EP2203186A4 (en) 2011-03-16
US8034329B2 (en) 2011-10-11
AU2008308531B2 (en) 2014-04-24
CA2701435C (en) 2017-06-20
EP2203186B1 (en) 2014-09-24
WO2009046335A1 (en) 2009-04-09
CN102036688B (zh) 2014-07-02
CA2701435A1 (en) 2009-04-09
JP5323845B2 (ja) 2013-10-23

Similar Documents

Publication Publication Date Title
ES2552226T3 (es) Reparación y regeneración de cartílago y hueso utilizando células derivadas posparto
ES2621847T3 (es) Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
US8034329B2 (en) Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
CA2747727C (en) Conditioned medium and methods of making the same
Bajpai et al. The human heart contains distinct macrophage subsets with divergent origins and functions
Cervello et al. Human endometrial side population cells exhibit genotypic, phenotypic and functional features of somatic stem cells
US20060171930A1 (en) Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
US8491883B2 (en) Treatment of amyotrophic lateral sclerosis using umbilical derived cells
Chen et al. Endometriosis stromal cells induce bone marrow mesenchymal stem cell differentiation and PD-1 expression through paracrine signaling
WO2019087130A2 (en) Method of inhibiting angiogenesis
Borazjani et al. Transcriptional regulation of connective tissue metabolism genes in women with pelvic organ prolapse
Lukacs et al. Epithelial stem cells of the prostate and their role in cancer progression
Gupta et al. Mouse Embryonic Fibroblasts Acquire Sarcomagenesis Potential after Differentiating into Insulin-Producing Cells